AstraZeneca’s antibody drug cut the danger of significant COVID-19 by at the very least 50 p.c in a late stage study, the company declared on Monday. The injection, termed AZD7442, has two different antibodies developed from the the blood of men and women who earlier contracted COVID-19. It’s the very first drug of […]